+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to Include Impact of COVID-19 Diagnostics 2021 to 2025

  • ID: 5214371
  • Report
  • February 2021
  • Region: Global
  • 363 Pages
  • Howe Sound Research
1 of 4
Covid-19 Drives PCR Market Expansion. New Multiplex Markets See Accelerated Development Outlook

FEATURED COMPANIES

  • Accelerate Diagnostics
  • Biocartis
  • Curetis
  • Hologic
  • Mobidiag
  • Quantumdx
  • MORE

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician’s Office or even the Home? Will digital PCR become the new lab standard?

The author's facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Accelerate Diagnostics
  • Biocartis
  • Curetis
  • Hologic
  • Mobidiag
  • Quantumdx
  • MORE

Market Guides

  • Situation Analysis
  • Guide for Executives and Marketing Staff
  • Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition
1.1 What are PCR Technologies?
1.2 PCR and Syndromic Testing
1.3 Market Definition
1.3.1 Market Size
1.3.2 Currency
1.3.3 Years
1.4 Methodology
1.4.1 Authors
1.4.2 Sources
1.5 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. PCR - Guide to PCR Technologies
2.1 Concepts
2.1.1 Method
2.2 Applications
2.2.1 Finding Specific DNA
2.2.2 Measuring DNA
2.2.3 Medical and diagnostic applications
2.2.3.1 Carrier, prenatal and tissue typing
2.2.3.2 Cancer Diagnosis and Management
2.2.3.3 Infectious disease - New Levels of Accuracy and Sensitivity
2.2.3.4 Forensic applications
2.2.3.5 Science and Research
2.3 PCR - Advantages and Disadvantages
2.4 Different Types of PCR
2.4.1 Simple Changes
2.4.1.1 Multiplex-PCR
2.4.1.2 VNTR PCR
2.4.1.3 Asymmetric PCR
2.4.1.4 Long PCR
2.4.1.5 Nested PCR
2.4.1.6 Quantitative PCR
2.4.1.7 Hot-start PCR
2.4.1.8 Touchdown PCR
2.4.1.9 Assembly PCR
2.4.1.10 Colony PCR
2.4.1.11 Suicide PCR
2.4.1.12 Cold PCR
2.4.2 Digital PCR
2.4.2.1 Droplet Digital PCR
2.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
2.4.2.3 Digital PCR in Use
2.4.2.4 Digital PCR Commercial History
2.4.3 Isothermal PCR

3. Industry Overview
3.1 Players in a Dynamic Market
3.1.1 Academic Research Lab
3.1.2 Diagnostic Test Developer
3.1.3 Genomic Instrumentation Supplier
3.1.3.1 Cell Separation and Viewing Instrumentation Supplier
3.1.4 Pharmaceutical/Reagent Supplier
3.1.5 Independent Testing Lab
3.1.6 Public National/regional lab
3.1.7 Hospital lab
3.1.8 Physician Lab
3.1.9 Audit Body
3.1.10 Certification Body

4. Market Trends
4.1 Factors Driving Growth
4.1.1 A New Standard
4.1.2 Down the Curve We Go
4.1.3 Multiplexing
4.1.4 Syndromic Diagnostics Looks Unstoppable
4.1.5 The Genetic Blizzard
4.2 Factors Limiting Growth
4.2.1 The Cost Curve
4.2.2 The Other Guys
4.2.3 Systemic Roadblocks
4.3 Diagnostic Technology Development
4.3.1 The Instrumentation Curve
4.3.2 Shifting Role of Diagnostics
4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
4.3.5 The Next Five Years

5. PCR Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section

  • Scope Fluidics Secures €6.2M Supporting Rapid MDx
  • Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
  • Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
  • Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
  • HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
  • Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
  • Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
  • DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
  • Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
  • ChromaCode Raises $28M based on new High Definition PCR Technology
  • ddPCR Used for Fast and Low-Cost NIPT Screening
  • Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
  • Bio-Rad's ddPCR MSI RUO Assay is available
  • ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
  • Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
  • QIAGEN Plans for Next-Generation Digital PCR Systems
  • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • New PCR Technology: Transfer-PCR (tPCR) Applications
  • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • Paragon Genomics, MGI Tech Form Distribution Alliance
  • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
  • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
  • Bruker to Acquire Majority in Hain Lifescience GmbH
  • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
  • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
  • PredictImmune Wins £100K Grant for Study of IBD Prognostic
  • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
  • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
  • Bio-Rad Wins USDA Food Safety Testing Contract
  • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets
7.1 PCR - Global Market Overview by Country
7.1.1 Table - Global Market by Country
7.1.2 Chart - Global Market by Country

8. Global PCR Markets - By Application
8.1 Global Market by Application - Overview
8.1.1 Table - Global Market by Application
8.1.2 Chart - Global Market by Application - Base/Final Comparison
8.1.3 Chart - Global Market by Application - Base Year
8.1.4 Chart - Global Market by Application - Final Year
8.1.4 Chart - Global Market by Application - Share by Year
8.2 PCR Clinical Multiplex
8.2.1 Table PCR Clinical Multiplex Testing - by Country
8.2.2 Chart - PCR Clinical Multiplex Testing Growth
8.3 PCR Clinical Singleplex
8.3.1 Table PCR Clinical Singleplex Testing - by Country
8.3.2 Chart - PCR Clinical Singleplex Testing Growth
8.4 PCR Research
8.4.1 Table PCR Research - by Country
8.4.2 Chart - PCR Research Growth
8.5 PCR Single C19
8.5.1 Table PCR Single C19 - by Country
8.5.2 Chart - PCR Single C19 Growth
8.6 PCR Other
8.6.1 Table PCR Other - by Country
8.6.2 Chart - PCR Other Growth

9. Global PCR Markets - By Technology
9.1 Global Market by Technology - Overview
9.1.1 Table - Global Market by Technology
9.1.2 Chart - Global Market by Technology - Base/Final Comparison
9.1.3 Chart - Global Market by Technology - Base Year
9.1.4 Chart - Global Market by Technology - Final Year
9.1.4 Chart - Global Market by Technology - Share by Year
9.2 qPCR
9.2.1 Table qPCR - by Country
9.2.2 Chart - qPCR Growth
9.3 dPCR
9.3.1 Table dPCR - by Country
9.3.2 Chart - dPCR Growth
9.4 Single C19 PCR
9.4.1 Table Single C19 PCR - by Country
9.4.2 Chart - Single C19 PCR Growth

Appendices

  • United States Medicare System: 2020 Clinical Laboratory Fees Schedule

List of Tables
Table 2 Lab Spending 2014 to 2024
Table 3 Market Players by Type
Table 4 Five Factors Driving Growth
Table 5 Three Factors Limiting Growth
Table 6 Global PCR Market by Region
Table 7 Global Market by Application
Table 8 PCR Clinical Multiplex by Country
Table 9 PCR Clinical Singleplex by Country
Table 10 PCR Research by Country
Table 11 PCR Single C19 by Country
Table 12 PCR Other by Country
Table 13 Global Market by Technology
Table 14 qPCR by Country
Table 15 dPCR by Country
Table 16 Single C19 PCR by Country
Table 17 2020 Clinical Lab Fee Schedule

List of Figures
Figure 2 Clinical Lab Spending 2014 to 2024
Figure 3 The PCR Process
Figure 4 Creation of Sample Droplets for Digital PCR
Figure 5 Comparing Syndromic and Targeted Testing
Figure 6 Comparing The New Diagnostics and Traditional Testing
Figure 7 Growth rates of PCR Diagnostic Segments
Figure 8 Base year Global Market Share Chart
Figure 9 PCR Market by Application - Base vs. final
Figure 10 PCR Market Base year
Figure 11 PCR Market Final Year
Figure 12 Application Share by Year
Figure 13 PCR Clinical Multiplex Testing Growth
Figure 14 PCR Clinical Singleplex Testing Growth
Figure 15 PCR Research Growth
Figure 16 PCR Single C19 Growth
Figure 17 PCR Other Growth
Figure 18 PCR Market by Technology - Base vs. Final
Figure 19 PCR Market Base Year
Figure 20 PCR Market Final Year
Figure 21 Technology Share by Year
Figure 22 qPCR Growth
Figure 23 dPCR Growth
Figure 24 Single C19 PCR Growth

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Bio-Rad Laboratories
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • Stilla Technologies
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics
Note: Product cover images may vary from those shown
Adroll
adroll